Niagen Bioscience launches drug candidate for rare genetic disease

Go back to Niagen Bioscience launches drug candidate for rare genetic disease
(NASDAQ: NAGE) Delayed: 2.99 -0.06 (1.97%)
Previous Close $3.05    52 Week High $ 
Open $3.04    52 Week Low $ 
Day High $3.07    P/E N/A 
Day Low $2.98    EPS $ 
Volume 20,331